These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27073470)

  • 1. Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG
    Alkhatatbeh MJ; Lincz LF; Thorne RF
    Exp Ther Med; 2016 Apr; 11(4):1487-1492. PubMed ID: 27073470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
    Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
    Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of metformin on mitochondrial pathway of apoptosis and oxidative stress in cell model of nonalcoholic fatty liver disease].
    Wu PB; Song Q; Yu YJ; Yu HG; Luo HS; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):64-68. PubMed ID: 32023702
    [No Abstract]   [Full Text] [Related]  

  • 4. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells.
    Vidyashankar S; Sandeep Varma R; Patki PS
    Toxicol In Vitro; 2013 Mar; 27(2):945-53. PubMed ID: 23348005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
    Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
    Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
    Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy.
    Khalifa O; H Mroue K; Mall R; Ullah E; S Al-Akl N; Arredouani A
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Acetyl-oleanolic acid ameliorates non-alcoholic fatty liver disease in high fat diet-treated rats by activating AMPK-related pathways.
    Ou-Yang Q; Xuan CX; Wang X; Luo HQ; Liu JE; Wang LL; Li TT; Chen YP; Liu J
    Acta Pharmacol Sin; 2018 Aug; 39(8):1284-1293. PubMed ID: 29345253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro.
    Liu Y; Wang D; Zhang D; Lv Y; Wei Y; Wu W; Zhou F; Tang M; Mao T; Li M; Ji B
    J Agric Food Chem; 2011 Nov; 59(22):12254-63. PubMed ID: 21999238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in HepG2 cells.
    Zhang DD; Zhang JG; Wu X; Liu Y; Gu SY; Zhu GH; Wang YZ; Liu GL; Li XY
    Front Pharmacol; 2015; 6():238. PubMed ID: 26539118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells.
    Vidyashankar S; Sharath Kumar LM; Barooah V; Sandeep Varma R; Nandakumar KS; Patki PS
    Phytomedicine; 2012 Oct; 19(13):1156-65. PubMed ID: 22940028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease.
    Zhao R; Zhu M; Zhou S; Feng W; Chen H
    Front Chem; 2020; 8():407. PubMed ID: 32548088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism.
    Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J
    Int Immunopharmacol; 2018 Dec; 65():256-267. PubMed ID: 30340105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.